Zdrowie i gospodarka · 21/09/2017
FDA Hosts Public Workshop on Pediatric Heart Failure Drug Development
The FDA is hosting a public workshop to discuss challenges in developing drugs for pediatric heart failure, including clinical trial design and endpoint evaluation, and to explore alternative approaches using registry data.
Source: Federal Register — Food and Drug AdministrationOpen original release →